Shire $18bn loan oversubscribed in syndication
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Syndicated LoansInvestment Grade Loans

Shire $18bn loan oversubscribed in syndication

Pills_230px

Pharmaceuticals firm Shire completed the syndication of an $18bn acquisition loan on Friday and will use proceeds to buy rare disease specialist Baxalta.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article